We conducted a prospective clinical and epidemiologic evaluation of 45
cases of human T lymphotropic virus type I (HTLV-1)-associated myelop
athy/tropical spastic paraparesis (HAM/TSP) in Sao Paulo, Brazil, All
enrolled patients had progressive chronic myelopathy and high titers o
f HTLV-I and HTLV-II antibodies, as determined by enzyme immunoassay a
nd western blot, In 24 cases, the polymerase chain reaction (PCR) was
performed so that HTLV-I could be distinguished from HTLV-II, The clin
ical and epidemiologic features of the patients from our study were si
milar to those of patients with HAM/TSP from other areas of endemicity
for HTLV-I except that more patients in our study had received a bloo
d transfusion prior to their illness, Despite the presence of HTLV-II
virus in Brazil, all patients whose serum was tested by PCR were found
to be infected with the HTLV-I virus.